We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04200456
Brief Title: A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP) (myOpportunITy1)

First Submitted : December 13, 2019
First Submitted that Met QC Criteria : December 13, 2019
First Posted : December 16, 2019

Last Update Submitted that Met QC Criteria : September 7, 2022
Last Update Posted : September 9, 2022